DEF 14AThe Ballot
BridgeBio Pharma, Inc. files DEF 14A
Filed Apr 30, 2025 · 1y ago · Accession 0001140361-25-016452
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- DEF 14A
- Filing date
- Apr 30, 2025
- Report date
- Jun 20, 2025
- Document
- ny20044444x2_def14a.htm
- Size
- 8.4 MB